Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study. [electronic resource]
Producer: 20131108Description: 3599-607 p. digitalISSN:- 1945-7197
- Adolescent
- Adult
- Blood Glucose
- Blood Pressure -- drug effects
- Body Composition -- drug effects
- Body Mass Index
- Drug Therapy, Combination
- Female
- Follicle Stimulating Hormone -- blood
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- blood
- Insulin Resistance
- Luteinizing Hormone -- blood
- Menstrual Cycle -- drug effects
- Metformin -- administration & dosage
- Mineralocorticoid Receptor Antagonists -- administration & dosage
- Polycystic Ovary Syndrome -- blood
- Spironolactone -- administration & dosage
- Testosterone -- blood
- Treatment Outcome
- Waist-Hip Ratio
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.